How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?

References

• Asthma + Lung UK What is asthma?; 2021. Available from: https://www.asthma.org.uk/advice/understanding-asthma/what-is-asthma/. Accessed December 11 11, 2023.
   Google Scholar
• GINA Difficult to Treat & Severe Asthma in adolescent and adult patients. Diagnosis and Management. A GINA pocket guide for health professionals. Version 3 0.April 2021; 2023. Available from: https://ginasthma.org/wp-content/uploads/2021/08/SA-Pocket-guide-v3.0-SCREEN-WMS.pdf. Accessed December 11, 2023.
   Google Scholar
• Barnes P, Woolcock A. Difficult asthma. Eur Respir J. 1998;12(5):1209–1218. doi:10.1183/09031936.98.12051209
   PubMed Web of Science ®Google Scholar
• Patel GB, Peters AT. Comorbidities associated with severe asthma. J Precis Respir Med. 2019;2(1):5–9. doi:10.2500/jprm.2019.190006
   PubMedGoogle Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC
   PubMed Web of Science ®Google Scholar
• Teague WG, Phillips BR, Fahy JV, et al. Baseline features of the severe asthma research program (SARP III) cohort: differences with age. J Allergy Clin Immunol Pract. 2018;6(2):545–554.e4. doi:10.1016/j.jaip.2017.05.032
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46(5):1308–1321. doi:10.1183/13993003.00779-2015
   PubMed Web of Science ®Google Scholar
• Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM. on behalf of the British thoracic society difficult asthma network. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax. 2010;65(9):787–794. doi:10.1136/thx.2010.137414
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Tran TN, Alacqua M, et al. International severe asthma registry (ISAR): protocol for a global registry. BMC Med Res Methodol. 2020;20(1):212. doi:10.1186/s12874-020-01065-0
   PubMed Web of Science ®Google Scholar
• Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377(10):965–976.
   PubMed Web of Science ®Google Scholar
• Azim A, Newell C, Barber C, et al. Clinical evaluation of type 2 disease status in a real‐world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts. Clin Exp Allergy. 2021;51(6):811–820. doi:10.1111/cea.13841
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386(2):157–171. doi:10.1056/NEJMra2032506
   PubMed Web of Science ®Google Scholar
• Chen W, Safari A, FitzGerald JM, Sin DD, Tavakoli H, Sadatsafavi M. Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study. Thorax. 2019;74(12):1113–1119. doi:10.1136/thoraxjnl-2019-213223
   PubMed Web of Science ®Google Scholar
• Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J. 1998;12(6):1322–1326. doi:10.1183/09031936.98.12061322
   PubMed Web of Science ®Google Scholar
• National Review of Asthma Deaths. Confidential Enquiry Report; 2014. Available from: https://www.rcplondon.ac.uk/projects/national-review-asthma-deaths. Accessed December 11, 2023.
   Google Scholar
• Azim A, Mistry H, Freeman A, et al. Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic. BMC Pulm Med. 2019;19(1):99. doi:10.1186/s12890-019-0862-2
   PubMedGoogle Scholar
• BTS/SIGN. SIGN 158: British guideline on the management of asthma; 2022. Available from: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/. Accessed December 11, 2023.
   Google Scholar
• Arshad SH, Holloway JW, Karmaus W, et al. Cohort profile: the isle of wight whole population birth cohort (IOWBC). Int J Epidemiol. 2018;47(4):1043–1044i. doi:10.1093/ije/dyy023
   PubMed Web of Science ®Google Scholar
• Chen W, FitzGerald JM, Lynd LD, Sin DD, Sadatsafavi M. Long-term trajectories of mild asthma in adulthood and risk factors of progression. J Allergy Clin Immunol Pract. 2018;6(6):2024–2032.e5. doi:10.1016/j.jaip.2018.04.027
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Boulet LP, Lavoie KL, Raherison-Semjen C, Singh D. Personalized treatment of asthma: the importance of sex and gender differences. J Allergy Clin Immunol Pract. 2022;10(4):963–971.e3. doi:10.1016/j.jaip.2022.02.002
   PubMed Web of Science ®Google Scholar
• Azim A, Freeman A, Lavenu A, et al. New perspectives on difficult asthma; sex and age of asthma-onset based phenotypes. J Allergy Clin Immunol Pract. 2020;8(10):3396–3406.e4. doi:10.1016/j.jaip.2020.05.053
   PubMed Web of Science ®Google Scholar
• Eisner MD, Yelin EH, Katz PP, et al. Predictors of cigarette smoking and smoking cessation among adults with asthma. Am J Public Health. 2000;90(8):1307–1311. doi:10.2105/AJPH.90.8.1307
   PubMed Web of Science ®Google Scholar
• Arshad SH, Hodgekiss C, Holloway JW, et al. Association of asthma and smoking with lung function impairment in adolescence and early adulthood: the isle of wight birth cohort study. Eur Respir J. 2020;55(3):1900477. doi:10.1183/13993003.00477-2019
   PubMed Web of Science ®Google Scholar
• Apostol GG, Jacobs DR, Tsai AW, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the coronary artery risk development in young adults study. Am J Respir Crit Care Med. 2002;166(2):166–172. doi:10.1164/rccm.2007035
   PubMed Web of Science ®Google Scholar
• Hylkema MN, Sterk PJ, de Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Respir J. 2007;29(3):438–445. doi:10.1183/09031936.00124506
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783–790. doi:10.1164/rccm.200511-1746OC
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006;174(2):127–133. doi:10.1164/rccm.200510-1589OC
   PubMed Web of Science ®Google Scholar
• Mistry H, Ajsivinac Soberanis HM, Kyyaly MA, et al. The clinical implications of aspergillus fumigatus sensitization in difficult-to-treat asthma patients. J Allergy Clin Immunol Pract. 2021;9(12):4254–4267.e10. doi:10.1016/j.jaip.2021.08.038
   PubMed Web of Science ®Google Scholar
• Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med. 2006;173(9):953–957. doi:10.1164/rccm.200511-1706PP
   PubMed Web of Science ®Google Scholar
• Sastre J, Crespo A, Fernandez-Sanchez A, et al. Anxiety, depression, and asthma control: changes after standardized treatment. J Allergy Clin Immunol Pract. 2018;6(6):1953–1959. doi:10.1016/j.jaip.2018.02.002
   PubMed Web of Science ®Google Scholar
• Fong WCG, Rafiq I, Harvey M, et al. The detrimental clinical associations of anxiety and depression with difficult asthma outcomes. J Pers Med. 2022;12(5):686. doi:10.3390/jpm12050686
   PubMed Web of Science ®Google Scholar
• Rimington LD. Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax. 2001;56(4):266–271. doi:10.1136/thorax.56.4.266
   PubMed Web of Science ®Google Scholar
• To T, Simatovic J, Zhu J, et al. Asthma deaths in a large provincial health system. A 10-year population-based study. Ann Am Thorac Soc. 2014;11(8):1210–1217. doi:10.1513/AnnalsATS.201404-138OC
   PubMedGoogle Scholar
• Varkonyi-Sepp J, Freeman A, Ainsworth B, Kadalayil LP, Haitchi HM, Kurukulaaratchy RJ. Multimorbidity in difficult asthma: the need for personalised and non-pharmacological approaches to address a difficult breathing syndrome. J Pers Med. 2022;12(9):1435. doi:10.3390/jpm12091435
   PubMed Web of Science ®Google Scholar
• Maison N, Omony J, Illi S, et al. T2-high asthma phenotypes across lifespan. Eur Respir J. 2022;60(3):2102288. doi:10.1183/13993003.02288-2021
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Busby J, Pfeffer PE, et al. Characterisation of patients with severe asthma in the UK severe asthma registry in the biologic era. Thorax. 2021;76(3):220–227. doi:10.1136/thoraxjnl-2020-215168
   PubMed Web of Science ®Google Scholar
• Barber C, Azim A, Newell C, et al. Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputum. Clin Exp Allergy. 2022;52(6):792–796. doi:10.1111/cea.14109
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Modrek B, Choy DF, et al. T-helper Type 2–driven Inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388–395. doi:10.1164/rccm.200903-0392OC
   PubMed Web of Science ®Google Scholar